Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19
Open Access
- 20 May 2020
- journal article
- letter
- Published by Elsevier BV in The Lancet Respiratory Medicine
- Vol. 8 (6), e48-e49
- https://doi.org/10.1016/s2213-2600(20)30237-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Diagnosing COVID-19-associated pulmonary aspergillosisThe Lancet Microbe, 2020
- COVID‐19 associated pulmonary aspergillosisMycoses, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Clinical and virological data of the first cases of COVID-19 in Europe: a case seriesThe Lancet Infectious Diseases, 2020
- Nucleic Acid Tools for Invasive Fungal Disease DiagnosisCurrent Fungal Infection Reports, 2020
- Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research ConsortiumClinical Infectious Diseases, 2019
- Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort studyThe Lancet Respiratory Medicine, 2018
- Circulating Aspergillus fumigatus DNA Is Quantitatively Correlated to Galactomannan in SerumFrontiers in Microbiology, 2017
- Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective studyIntensive Care Medicine, 2012
- A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2012